Feb 28 |
Exscientia to Present at Upcoming Investor Conferences in March
|
Feb 26 |
Exscientia: A Strategic Hold In The AI-Driven Drug Discovery Sector (Rating Downgrade)
|
Feb 13 |
Exscientia CEO terminated from position due to inappropriate conduct - filing
|
Feb 13 |
Oxford drug company sacks chief executive over ‘inappropriate’ relationships with staff
|
Feb 13 |
Exscientia fires CEO after probe over relationship with two employees
|
Feb 7 |
Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients
|
Jan 25 |
The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech Breakthroughs
|
Jan 2 |
M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024
|
Jan 2 |
Professor Andrew L. Hopkins appointed Commander of the Order of the British Empire (CBE)
|
Dec 30 |
Ozempic drugmaker to open AI research hub in King’s Cross
|